Literature DB >> 7833150

Should clinicians be concerned about the carcinogenic potential of tamoxifen?

V C Jordan1, M Morrow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7833150     DOI: 10.1016/0959-8049(94)00349-a

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  11 in total

Review 1.  Tamoxifen in postmenopausal women a safety perspective.

Authors:  E Robinson; G G Kimmick; H B Muss
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

Review 2.  Comparative tolerability of first-generation selective estrogen receptor modulators in breast cancer treatment and prevention.

Authors:  M G Curtis
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 3.  Tamoxifen and secondary tumours. An update.

Authors:  N Wilking; E Isaksson; E von Schoultz
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

4.  The SERM Saga, Something from Nothing: American Cancer Society/SSO Basic Science Lecture.

Authors:  V Craig Jordan
Journal:  Ann Surg Oncol       Date:  2019-03-25       Impact factor: 5.344

Review 5.  Efficacy and economics of hormonal therapies for advanced breast cancer.

Authors:  Michael S Simon; Dina Ibrahim; Lisa Newman; Miron Stano
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 6.  Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

Review 7.  Selective estrogen receptor modulators and phytoestrogens.

Authors:  Tawakalitu Oseni; Roshani Patel; Jennifer Pyle; V Craig Jordan
Journal:  Planta Med       Date:  2008-10-08       Impact factor: 3.352

8.  The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells.

Authors:  Adele Vivacqua; Anna Grazia Recchia; Giovanna Fasanella; Sabrina Gabriele; Amalia Carpino; Vittoria Rago; Maria Luisa Di Gioia; Antonella Leggio; Daniela Bonofiglio; Angelo Liguori; Marcello Maggiolini
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

Review 9.  Successful Targeted Therapies for Breast Cancer: the Worcester Foundation and Future Opportunities in Women's Health.

Authors:  Balkees Abderrahman; V Craig Jordan
Journal:  Endocrinology       Date:  2018-08-01       Impact factor: 4.736

10.  Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatment.

Authors:  S Ciatto; S Cecchini; G Gervasi; A Landini; M Zappa; E Crocetti
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.